BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

433 related articles for article (PubMed ID: 26601566)

  • 1. Frequency of residual melanoma in wide local excision (WLE) specimens after complete excisional biopsy.
    Bolshinsky V; Lin MJ; Serpell J; Leung M; Wolfe R; McLean C; Kelly JW
    J Am Acad Dermatol; 2016 Jan; 74(1):102-7. PubMed ID: 26601566
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Residual melanoma in wide local excision specimens after 'complete' excision of primary cutaneous in situ and invasive melanomas.
    Jackett LA; Satgunaseelan L; Roper E; Lo SN; Thompson JF; Scolyer RA
    Pathology; 2022 Feb; 54(1):71-78. PubMed ID: 34392983
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of biopsy type on outcomes in the treatment of primary cutaneous melanoma.
    Mills JK; White I; Diggs B; Fortino J; Vetto JT
    Am J Surg; 2013 May; 205(5):585-90; discussion 590. PubMed ID: 23592167
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Residual melanoma after an excisional biopsy is an independent prognostic factor for local recurrence and overall survival.
    Hocevar M; Dragonja Z; Pilko G; Gazic B; Zgajnar J
    Eur J Surg Oncol; 2014 Oct; 40(10):1271-5. PubMed ID: 24656456
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A retrospective observational study of primary cutaneous malignant melanoma patients treated with excision only compared with excision biopsy followed by wider local excision.
    McKenna DB; Lee RJ; Prescott RJ; Doherty VR
    Br J Dermatol; 2004 Mar; 150(3):523-30. PubMed ID: 15030337
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The impact of biopsy technique on upstaging, residual disease, and outcome in cutaneous melanoma.
    Egnatios GL; Dueck AC; Macdonald JB; Laman SD; Warschaw KE; DiCaudo DJ; Nemeth SA; Sekulic A; Gray RJ; Wasif N; Pockaj BA
    Am J Surg; 2011 Dec; 202(6):771-7; discussion 777-8. PubMed ID: 22000117
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk Factors Predicting Positive Margins at Primary Wide Local Excision of Cutaneous Melanoma.
    Mangold AR; Skinner R; Dueck AC; Sekulic A; Pockaj BA
    Dermatol Surg; 2016 May; 42(5):646-52. PubMed ID: 27082057
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Accuracy of lymphatic mapping and sentinel lymph node biopsy after previous wide local excision in patients with primary melanoma.
    Gannon CJ; Rousseau DL; Ross MI; Johnson MM; Lee JE; Mansfield PF; Cormier JN; Prieto VG; Gershenwald JE
    Cancer; 2006 Dec; 107(11):2647-52. PubMed ID: 17063497
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of Mohs Micrographic Surgery vs Wide Local Excision With Overall Survival Outcomes for Patients With Melanoma of the Trunk and Extremities.
    Demer AM; Hanson JL; Maher IA; Liszewski W
    JAMA Dermatol; 2021 Jan; 157(1):84-89. PubMed ID: 33084853
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Does Residual Invasive Disease in Wide Local Excision after Diagnosis with Partial Biopsy Technique Influence Survival in Melanoma? Matched-Pair Analysis of Multicenter Selective Lymphadenectomy Trial I and II.
    Ramiscal JAB; Stern SL; Wilson AK; Lorimer PD; Lee NA; Goldfarb MR; Foshag LJ; Fischer TD
    J Am Coll Surg; 2022 Jul; 235(1):49-59. PubMed ID: 35703962
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk factors for positive or equivocal margins after wide local excision of 1345 cutaneous melanomas.
    Miller CJ; Shin TM; Sobanko JF; Sharkey JM; Grunyk JW; Elenitsas R; Chu EY; Capell BC; Ming ME; Etzkorn JR
    J Am Acad Dermatol; 2017 Aug; 77(2):333-340.e1. PubMed ID: 28711085
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sentinel lymph node biopsy for the T1 (thin) melanoma: is it necessary?
    Nahabedian MY; Tufaro AP; Manson PN
    Ann Plast Surg; 2003 Jun; 50(6):601-6. PubMed ID: 12783009
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Frequency of and risk factors for tumor upstaging after wide local excision of primary cutaneous melanoma.
    Etzkorn JR; Sharkey JM; Grunyk JW; Shin TM; Sobanko JF; Miller CJ
    J Am Acad Dermatol; 2017 Aug; 77(2):341-348. PubMed ID: 28601390
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Defining the role of CD2 in disease progression and overall survival among patients with completely resected stage-II to -III cutaneous melanoma.
    Harcharik S; Bernardo S; Moskalenko M; Pan M; Sivendran M; Bell H; Hall LD; Castillo-Martín M; Fox K; Cordon-Cardo C; Chang R; Sivendran S; Phelps RG; Saenger Y
    J Am Acad Dermatol; 2014 Jun; 70(6):1036-44. PubMed ID: 24698703
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Association Between Excision Margins and Local Recurrence in 11,290 Thin (T1) Primary Cutaneous Melanomas: A Case-Control Study.
    MacKenzie Ross AD; Haydu LE; Quinn MJ; Saw RP; Shannon KF; Spillane AJ; Stretch JR; Scolyer RA; Thompson JF
    Ann Surg Oncol; 2016 Apr; 23(4):1082-9. PubMed ID: 26561405
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Outcome following sentinel node biopsy plus wide local excision versus wide local excision only for primary cutaneous melanoma: analysis of 5840 patients treated at a single institution.
    van der Ploeg AP; Haydu LE; Spillane AJ; Quinn MJ; Saw RP; Shannon KF; Stretch JR; Uren RF; Scolyer RA; Thompson JF
    Ann Surg; 2014 Jul; 260(1):149-57. PubMed ID: 24633018
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Desmoplastic melanoma: a 12-year experience with sentinel lymph node biopsy.
    Broer PN; Walker ME; Goldberg C; Buonocore S; Braddock DT; Lazova R; Narayan D; Ariyan S
    Eur J Surg Oncol; 2013 Jul; 39(7):681-5. PubMed ID: 23522951
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Desmoplastic and neurotropic melanoma.
    Su LD; Fullen DR; Lowe L; Wang TS; Schwartz JL; Cimmino VM; Sondak VK; Johnson TM
    Cancer; 2004 Feb; 100(3):598-604. PubMed ID: 14745878
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sentinel-node biopsy or nodal observation in melanoma.
    Morton DL; Thompson JF; Cochran AJ; Mozzillo N; Elashoff R; Essner R; Nieweg OE; Roses DF; Hoekstra HJ; Karakousis CP; Reintgen DS; Coventry BJ; Glass EC; Wang HJ;
    N Engl J Med; 2006 Sep; 355(13):1307-17. PubMed ID: 17005948
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Highly sensitive multivariable assay detection of melanocytic differentiation antigens and angiogenesis biomarkers in sentinel lymph nodes with melanoma micrometastases.
    Vitoux D; Mourah S; Kerob D; Verola O; Basset-Seguin N; Baccard M; Schartz N; Ollivaud L; Archimbaud A; Servant JM; Revol M; Toubert ME; Podgorniak MP; Plassa F; Porcher R; Lebbé C
    Arch Dermatol; 2009 Oct; 145(10):1105-13. PubMed ID: 19841396
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.